238 related articles for article (PubMed ID: 20610624)
21. miRNA-205 suppresses melanoma cell proliferation and induces senescence via regulation of E2F1 protein.
Dar AA; Majid S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M
J Biol Chem; 2011 May; 286(19):16606-14. PubMed ID: 21454583
[TBL] [Abstract][Full Text] [Related]
22. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
[TBL] [Abstract][Full Text] [Related]
23. microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer.
Amponsah PS; Fan P; Bauer N; Zhao Z; Gladkich J; Fellenberg J; Herr I
Cancer Lett; 2017 Mar; 388():107-117. PubMed ID: 27940128
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-410 functions as a tumor suppressor by targeting angiotensin II type 1 receptor in pancreatic cancer.
Guo R; Gu J; Zhang Z; Wang Y; Gu C
IUBMB Life; 2015 Jan; 67(1):42-53. PubMed ID: 25646808
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer.
Mittal A; Chitkara D; Behrman SW; Mahato RI
Biomaterials; 2014 Aug; 35(25):7077-87. PubMed ID: 24836307
[TBL] [Abstract][Full Text] [Related]
26. miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death.
Chen Z; Sangwan V; Banerjee S; Mackenzie T; Dudeja V; Li X; Wang H; Vickers SM; Saluja AK
Mol Cancer; 2013 Sep; 12(1):105. PubMed ID: 24025188
[TBL] [Abstract][Full Text] [Related]
27. Expression of Selected miRNAs in Undifferentiated Carcinoma with Osteoclast-like Giant Cells (UCOGC) of the Pancreas: Comparison with Poorly Differentiated Pancreatic Ductal Adenocarcinoma.
Popov A; Hrudka J; Szabó A; Oliverius M; Šubrt Z; Vránová J; Ciprová V; Moravcová J; Mandys V
Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790924
[TBL] [Abstract][Full Text] [Related]
28. Blood-based microRNA profiling unveils complex molecular dynamics in breast cancer.
Shahid M; Syed R; Ansari MA; Shafi G; John J
J Appl Genet; 2024 Mar; ():. PubMed ID: 38478327
[TBL] [Abstract][Full Text] [Related]
29. Propranolol inhibits EMT and metastasis in breast cancer through miR-499-5p-mediated Sox6.
Zheng B; Du P; Zeng Z; Cao P; Ma X; Jiang Y
J Cancer Res Clin Oncol; 2024 Jan; 150(2):59. PubMed ID: 38294713
[TBL] [Abstract][Full Text] [Related]
30. Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer.
Pal A; Ojha A; Ju J
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139352
[TBL] [Abstract][Full Text] [Related]
31. KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients.
Lavacchi D; Polvani S; Taddei A; Scolari F; Messerini L; Caliman E; Moraldi L; Guidolin A; Grazi GL; Galli A; Pillozzi S; Antonuzzo L
Front Oncol; 2023; 13():1295936. PubMed ID: 38130990
[TBL] [Abstract][Full Text] [Related]
32. Targeting
Elhariri A; Alhaj A; Ahn D; Sonbol MB; Bekaii-Saab T; Wu C; Rutenberg MS; Stauffer J; Starr J; Majeed U; Jones J; Borad M; Babiker H
World J Clin Oncol; 2023 Aug; 14(8):285-296. PubMed ID: 37700806
[TBL] [Abstract][Full Text] [Related]
33. The Role of MicroRNAs in Pancreatitis Development and Progression.
Patel HR; Diaz Almanzar VM; LaComb JF; Ju J; Bialkowska AB
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674571
[TBL] [Abstract][Full Text] [Related]
34. miR-4653-3p overexpression is associated with a poor prognosis of pancreatic ductal adenocarcinoma via HIPK2 downregulation.
Hirabayashi K; Miyazawa M; Takanashi Y; Morimachi M; Kawanishi A; Saika T; Nakagohri T; Nakamura N
Sci Rep; 2022 Oct; 12(1):17927. PubMed ID: 36289359
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA hsa_circ_0007367 promotes the progression of pancreatic ductal adenocarcinoma by sponging miR-6820-3p and upregulating YAP1 expression.
Zhang H; Ma X; Wang L; Li X; Feng D; Liu M; Li J; Cheng M; Song N; Yang X; Ba L; Lei Y; Zhang R; Zhu Y; Xu W; Qiao G
Cell Death Dis; 2022 Aug; 13(8):736. PubMed ID: 36008392
[TBL] [Abstract][Full Text] [Related]
36. Identification of the Key miRNAs and Genes Associated with the Regulation of Non-Small Cell Lung Cancer: A Network-Based Approach.
Shafat Z; Ahmed MM; Almajhdi FN; Hussain T; Parveen S; Ahmed A
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885958
[TBL] [Abstract][Full Text] [Related]
37. Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review.
Jothimani G; Bhatiya M; Pathak S; Paul S; Banerjee A
Recent Adv Inflamm Allergy Drug Discov; 2022; 16(1):5-15. PubMed ID: 35670340
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-96: A therapeutic and diagnostic tumor marker.
Rahimi HR; Mojarrad M; Moghbeli M
Iran J Basic Med Sci; 2022 Jan; 25(1):3-13. PubMed ID: 35656454
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy.
Dai H; Abdullah R; Wu X; Li F; Ma Y; Lu A; Zhang G
Front Cell Dev Biol; 2022; 10():855474. PubMed ID: 35652096
[TBL] [Abstract][Full Text] [Related]
40. Emerging role of non-coding RNAs in the regulation of KRAS.
Ghafouri-Fard S; Shirvani-Farsani Z; Hussen BM; Taheri M; Jalili Khoshnoud R
Cancer Cell Int; 2022 Feb; 22(1):68. PubMed ID: 35139853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
